Elfriede Noessner

7PUBLICATIONS
15CO-AUTHORS
Cancer therapy (excl. chemotherapy and radiation therapy)Innate immunityHaematological tumoursMolecular targetsTumour immunology
Featured researcher

Get your video featured.

JoVEPublish with JoVE
Journal

Publications (7)

|Mar 21, 2025
Early recovery of leukocyte subsets is associated with favorable progression-free survival in patients with inoperable stage II/III NSCLC after multimodal treatment: a prospective explorative study.

Thomas P Hofer, Alexander E Nieto, Lukas Käsmann

|Sep 28, 2023
A Lysine Residue at the C-Terminus of MHC Class I Ligands Correlates with Low C-Terminal Proteasomal Cleavage Probability.

Adrian Schmalen, Ilona E Kammerl, Silke Meiners

|Oct 27, 2022
Dendritic Cells or Macrophages? The Microenvironment of Human Clear Cell Renal Cell Carcinoma Imprints a Mosaic Myeloid Subtype Associated with Patient Survival.

Dorothee Brech, Anna S Herbstritt, Sarah Diederich

|Sep 09, 2022
Identification of EZH2 as Cancer Stem Cell Marker in Clear Cell Renal Cell Carcinoma and the Anti-Tumor Effect of Epigallocatechin-3-Gallate (EGCG).

Chen Lyu, Lili Wang, Birgit Stadlbauer

|Apr 23, 2022
T-Cells Expressing a Highly Potent PRAME-Specific T-Cell Receptor in Combination with a Chimeric PD1-41BB Co-Stimulatory Receptor Show a Favorable Preclinical Safety Profile and Strong Anti-Tumor Reactivity.

Nadja Sailer, Ina Fetzer, Melanie Salvermoser

|Dec 10, 2021
Checkpoint Inhibition in Bladder Cancer: Clinical Expectations, Current Evidence, and Proposal of Future Strategies Based on a Tumor-Specific Immunobiological Approach.

Mariangela Mancini, Marialaura Righetto, Elfriede Noessner

Pageof 2

Frequent Collaborators

1 joint publications

Sebastian J Schober

1 joint publications

Busheng Xue

1 joint publications

Guenther H S Richter

1 joint publications

Michael W Pfaffl